X0306 4 2019-03-04 0 0001668243 UroGen Pharma Ltd. URGN 0001763581 Schoenberg Mark C/O UROGEN PHARMA LTD. 9 HA?TA?ASIYA STREET RA?ANANA L3 4365007 ISRAEL 0 1 0 0 Chief Medical Officer Ordinary Shares 2019-03-04 4 M 0 1042 A 6329 D Ordinary Shares 2019-03-06 4 S 0 1991 37.30 D 4338 D Restricted Stock Units (RSUs) 2019-03-04 4 M 0 1042 0.00 D Ordinary Shares 1042 7292 D Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. On December 7, 2017, the reporting person was granted restricted stock units ("RSUs") representing 12,500 ordinary shares. 1/3rd of the RSUs vested on December 4, 2018, with the balance vesting in equal quarterly installments thereafter over a period of two years, with the issuance of the underlying shares for the March 4, 2019 installment delayed until March 5, 2019. /s/ Peter Pfreundschuh, Attorney-in-Fact 2019-03-07